SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-092307
Filing Date
2016-04-01
Accepted
2016-04-01 16:17:26
Documents
10
Period of Report
2016-04-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v435857_8k.htm 8-K 19238
2 EXHIBIT 99.1 v435857_ex99-1.htm EX-99.1 8925
3 EXHIBIT 99.2 v435857_ex99-2.htm EX-99.2 8716
4 EXHIBIT 99.3 v435857_ex99-3.htm EX-99.3 7862
5 EXHIBIT 99.4 v435857_ex99-4.htm EX-99.4 6853
6 GRAPHIC image_001.jpg GRAPHIC 17241
7 GRAPHIC ex99x1_001.jpg GRAPHIC 154510
8 GRAPHIC ex99x2_001.jpg GRAPHIC 148171
9 GRAPHIC ex99x3_001.jpg GRAPHIC 157501
10 GRAPHIC ex99x4_001.jpg GRAPHIC 141531
  Complete submission text file 0001144204-16-092307.txt   906023
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 161547353
SIC: 2834 Pharmaceutical Preparations